Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
No predictors of response were identified except for levels of sexual function at baseline.
VRI and AVD techniques demonstrated the ability to diminish itching sensations temporarily.
Blood-pressure-lowering efficacy was similar between the 2 regimens throughout 24 hours, despite different elimination half-lives of telmisartan and losartan.
Losartan and bisoprolol have beneficial short-term ECG repolarization effects.
Of studies that met inclusion criteria, none demonstrated that testosterone therapy for hypogonadism increased prostate cancer risk or increased Gleason grade of cancer detected in treated vs untreated men.
Both combinations were similarly effective in reducing ambulatory and clinical BP in very older adults hypertensives.
Anastrozole administration normalized androgen production in older hypogonadal men and decreased estradiol production modestly.
The results of this study showed that the therapeutic effects of both finasteride gel and finasteride tablet were relatively similar to each other.
Percentages of change in GFR improved significantly with both treatments.
These results showed that adding ezetimibe to atorvastatin 40 mg was significantly more effective than uptitrating to atorvastatin 80 mg at lowering LDL cholesterol and other lipid parameters.
The incidences of clinical and laboratory adverse experiences were generally similar between groups.
Amlodipine safely reduces systolic blood pressure and it may have a beneficial effect on heart and blood vessel outcomes in hypertensive haemodialysis patients.
Both atorvastatin and fenofibrate have dual regulatory effects on VLDL-apoC-III kinetics in MetS; reduced production and increased fractional catabolism of VLDL-apoC-III may explain the triglyceride-lowering effect of these...
Treatment of PCOS patients with MPA provided good menstrual cycle control, beneficial changes in hormonal values associated with hyperandrogenism, and no significant changes in lipid or carbohydrate metabolism.
Participants with moderate to severe inflammatory acne did not show an increase in inflammatory lesions compared with participants treated with VEH.
Rosuvastatin 20 mg significantly reduced plasma LDL-cholesterol, triacylglycerol and total ApoB.
Intensive combined treatment provides superior acute and long-term effects over standard treatment in chronically depressed inpatients.
Despite similar BP control, telmisartan attenuated autonomic balance more effectively than enalapril.
Parents were satisfied with these results.
The committee noted significant duplication of data reported in this manuscript with data reported in another report (PMID: 19732888; https://doi.org/10.1016/j.fertnstert.2009.07.985) pertaining to a different study group that...
Women's preferences were similar to men when using these two drugs.
Pioglitazone treatment was followed by decreased lumbar and hip BMD and decreased measures of bone turnover in a premenopausal study population relatively protected from bone mineral loss.
This study suggests that hormone replacement therapy with estrogens or in combination with MPA may benefit the function of resistance arteries and may preserve the morphological integrity of endothelial cells by regulatory...
HOMA-IR was improved in the telmisartan group (3.1+/-1.1 to 1.6+/-0.7; p<0.01), but there was no difference in the nifedipine group (2.8+/-1.1 to 2.4+/-0.7; n.s.).
Myo-inositol administration improves reproductive axis functioning in PCOS patients reducing the hyperinsulinemic state that affects LH secretion.
Two 60 cm2 patches, allowed constant physiological levels of sexual hormones over time.
Higher dose rosuvastatin may also decrease LDL apoB production.
There were no statistically significant differences in the risk of developing RA or the severity of RA between the PHT and placebo groups.
Rosuvastatin was significantly (p<0.01) more effective than atorvastatin in decreasing sdLDL cholesterol (-53% vs -46%), direct LDL cholesterol (-52% vs -50%), total cholesterol/HDL.
The ALLHAT findings fail to support the preference for calcium channel blockers, alpha-blockers, or angiotensin-converting enzyme inhibitors compared with thiazide-type diuretics in patients with the MetS, despite their more...
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
